The history of Viagra presents a challenging picture for those considering investment. While the initial launch generated massive gains, the expiration of its intellectual property protection opened the floodgates to generic competitors, dramatically reducing sales. This creates a unique risk for drug manufacturers banking on comparable blockbuster

The story of Viagra, and its creator copyright, presents a challenging case study for investors. At first a blockbuster drug, generating billions in revenue , its intellectual property lapse created a wave of lower-priced alternatives , significantly eroding its check here position . While some businesses may seek to capitalize on male sexual dysfu